Published in Drug Week, April 2nd, 2004
Plattner will focus on the continued development of technology initially created by Anacor Co-Founders Lucy Shapiro at Stanford University and Stephen Benkovic at Pennsylvania State University. Anacor is using this research base to develop drugs for relevant biowarfare pathogens such as anthrax and tularemia, hospital infections caused by staphylococcus...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week